The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Salinomycin as a Drug for Targeting Human Cancer Stem Cells
Open accessAbstract
Cancer stem cells (CSCs) represent a subpopulation of tumor cells that possess self-renewal and tumor initiation capacity and the ability to give rise to the heterogenous lineages of malignant cells that comprise a tumor. CSCs possess multiple intrinsic mechanisms of resistance to chemotherapeutic drugs, novel tumor-targeted drugs, and radiation therapy, allowing them to survive standard cancer therapies and to initiate tumor recurrence and metastasis. Various molecular complexes and pathways that confer resistance and survival of CSCs, including expression of ATP-binding cassette (ABC) drug transporters, activation of the Wnt/β-catenin, Hedgehog, Notch and PI3K/Akt/mTOR signaling pathways, and acquisition of epithelial-mesenchymal transition (EMT), have been identified recently. Salinomycin, a polyether ionophore antibiotic isolated from Streptomyces albus, has been shown to kill CSCs in different types of human cancers, most likely by interfering with ABC drug transporters, the Wnt/β-catenin signaling pathway, and other CSC pathways. Promising results from preclinical trials in human xenograft mice and a few clinical pilote studies reveal that salinomycin is able to effectively eliminate CSCs and to induce partial clinical regression of heavily pretreated and therapy-resistant cancers. The ability of salinomycin to kill both CSCs and therapy-resistant cancer cells may define the compound as a novel and an effective anticancer drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H. M., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,051
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
The cancer stem cell: premises, promises and challenges
Clevers, H. (2011) · Nature Medicine · doi:10.1038/nm.2304 · Cited by 1,923
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.054 · Cited by 1,910
The epigenetic progenitor origin of human cancer
Feinberg, A. P., Ohlsson, R., & Henikoff, S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1748 · Cited by 1,853
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804
Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D., Black, K. L., & Yu, J. S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-67 · Cited by 1,790
Applying the principles of stem-cell biology to cancer
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1232 · Cited by 1,624
Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways
Onder, T. T., Gupta, P. B., Mani, S. A., Yang, J., Lander, E. S., & Weinberg, R. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2938 · Cited by 1,522
Visvader, J. E. (2011) · Nature · doi:10.1038/nature09781 · Cited by 1,449
Creighton, C. J., Li, X., Landis, M., Dixon, J. M., Neumeister, V. M., Sjolund, A., Rimm, D. L., Wong, H., Rodriguez, A., Herschkowitz, J. I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905718106 · Cited by 1,412
Molecular Definition of Breast Tumor Heterogeneity
Shipitsin, M., Campbell, L. L., Argani, P., Weremowicz, S., Bloushtain-Qimron, N., Yao, J., Nikolskaya, T., Serebryiskaya, T., Beroukhim, R., Hu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.013 · Cited by 1,353
The Response of CD24 −/low /CD44 + Breast Cancer–Initiating Cells to Radiation
Phillips, T. M., McBride, W. H., & Pajonk, F. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj495 · Cited by 1,309
Cancer Stem Cells: Current Status and Evolving Complexities
Visvader, J. E., & Lindeman, G. J. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.007 · Cited by 1,287
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Shackleton, M., Quintana, E., Fearon, E. R., & Morrison, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.08.017 · Cited by 1,162
Hirsch, H. A., Iliopoulos, D., Tsichlis, P. N., & Struhl, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2994 · Cited by 1,115
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Magee, J. A., Piskounova, E., & Morrison, S. J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.003 · Cited by 1,101
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4
Todaro, M., Alea, M. P., Di Stefano, A. B., Cammareri, P., Vermeulen, L., Iovino, F., Tripodo, C., Russo, A., Gulotta, G., Medema, J. P., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.001 · Cited by 1,039
Stem cell concepts renew cancer research
Dick, J. E. (2008) · Blood · doi:10.1182/blood-2008-08-077941 · Cited by 1,010
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
Takebe, N., Harris, P. J., Warren, R. Q., & Ivy, S. P. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.196 · Cited by 992
The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells
Liu, R., Wang, X., Chen, G. Y., Dalerba, P., Gurney, A., Hoey, T., Sherlock, G., Lewicki, J., Shedden, K., & Clarke, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063994 · Cited by 985
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
Zhao, C., Chen, A., Jamieson, C. H., Fereshteh, M., Abrahamsson, A., Blum, J., Kwon, H. Y., Kim, J., Chute, J. P., Rizzieri, D., et al. (2009) · Nature · doi:10.1038/nature07737 · Cited by 869
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
Zhou, B.-B. S., Zhang, H., Damelin, M., Geles, K. G., Grindley, J. C., & Dirks, P. B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2137 · Cited by 841
Exploring the role of cancer stem cells in radioresistance
Baumann, M., Krause, M., & Hill, R. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2419 · Cited by 815
Ma, S., Lee, T. K., Zheng, B.-J., Chan, K. W., & Guan, X.-Y. (2008) · Oncogene · doi:10.1038/sj.onc.1210811 · Cited by 775
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Ginestier, C., Liu, S., Diebel, M. E., Korkaya, H., Luo, M., Brown, M., Wicinski, J., Cabaud, O., Charafe-Jauffret, E., Birnbaum, D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39397 · Cited by 747
Charafe-Jauffret, E., Ginestier, C., Iovino, F., Tarpin, C., Diebel, M., Esterni, B., Houvenaeghel, G., Extra, J.-M., Bertucci, F., Jacquemier, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1630 · Cited by 732
Butaye, P., Devriese, L. A., & Haesebrouck, F. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.175-188.2003 · Cited by 712
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Wu, A., Wei, J., Kong, L.-Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., & Heimberger, A. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq082 · Cited by 691
The therapeutic promise of the cancer stem cell concept
Frank, N. Y., Schatton, T., & Frank, M. H. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41004 · Cited by 636
Wang, Z., Li, Y., Kong, D., Banerjee, S., Ahmad, A., Azmi, A. S., Ali, S., Abbruzzese, J. L., Gallick, G. E., & Sarkar, F. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4312 · Cited by 619
Breast cancer stem cells, cytokine networks, and the tumor microenvironment
Korkaya, H., Liu, S., & Wicha, M. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57099 · Cited by 616
WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells
Woodward, W. A., Chen, M. S., Behbod, F., Alfaro, M. P., Buchholz, T. A., & Rosen, J. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606599104 · Cited by 603
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
Dylla, S. J., Beviglia, L., Park, I.-K., Chartier, C., Raval, J., Ngan, L., Pickell, K., Aguilar, J., Lazetic, S., Smith-Berdan, S., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002428 · Cited by 589
Tanei, T., Morimoto, K., Shimazu, K., Kim, S. J., Tanji, Y., Taguchi, T., Tamaki, Y., & Noguchi, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1479 · Cited by 574
A Primary Role for K+ and Na+ Efflux in the Activation of Apoptosis
Bortner, C. D., Hughes, F. M., & Cidlowski, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32436 · Cited by 555
Metabolic state of glioma stem cells and nontumorigenic cells
Vlashi, E., Lagadec, C., Vergnes, L., Matsutani, T., Masui, K., Poulou, M., Popescu, R., Della Donna, L., Evers, P., Dekmezian, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106704108 · Cited by 553
Epigenetic modifications in cancer
Kanwal, R., & Gupta, S. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01809.x · Cited by 550
Bhatia, R., Holtz, M., Niu, N., Gray, R., Snyder, D. S., Sawyers, C. L., Arber, D. A., Slovak, M. L., & Forman, S. J. (2003) · Blood · doi:10.1182/blood-2002-09-2780 · Cited by 547
Regulation of mammary stem/progenitor cells by PTEN/Akt/β-catenin signaling
Korkaya, H., Paulson, A., Charafe-Jauffret, E., Ginestier, C., Brown, M., Dutcher, J., Clouthier, S. G., & Wicha, M. S. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000121 · Cited by 523
Hambardzumyan, D., Becher, O. J., Rosenblum, M. K., Pandolfi, P. P., Manova-Todorova, K., & Holland, E. C. (2008) · Genes & Development · doi:10.1101/gad.1627008 · Cited by 468
Sachlos, E., Risueño, R. M., Laronde, S., Shapovalova, Z., Lee, J.-H., Russell, J., Malig, M., McNicol, J. D., Fiebig-Comyn, A., Graham, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.049 · Cited by 456
The Actinomycetes. Vol. II. Classification, Identification and Descriptions of Genera and Species.
Waksman, S. A. (1961) · Cited by 438
Preferential induction of apoptosis for primary human leukemic stem cells
Guzman, M. L., Swiderski, C. F., Howard, D. S., Grimes, B. A., Rossi, R. M., Szilvassy, S. J., & Jordan, C. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252462599 · Cited by 426
ABC Transporters, Drug Resistance, and Cancer Stem Cells
Dean, M. (2009) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-009-9109-9 · Cited by 425
Bayet-Robert, M., Kwiatowski, F., Leheurteur, M., Gachon, F., Planchat, E., Abrial, C., Mouret-Reynier, M.-A., Durando, X., Barthomeuf, C., & Chollet, P. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.1.10392 · Cited by 399
Kanai, M., Yoshimura, K., Asada, M., Imaizumi, A., Suzuki, C., Matsumoto, S., Nishimura, T., Mori, Y., Masui, T., Kawaguchi, Y., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1470-2 · Cited by 399
Lu, D., Choi, M. Y., Yu, J., Castro, J. E., Kipps, T. J., & Carson, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110431108 · Cited by 395
Radiation Resistance of Cancer Stem Cells: The 4 R's of Radiobiology Revisited
Pajonk, F., Vlashi, E., & McBride, W. H. (2010) · Stem Cells · doi:10.1002/stem.318 · Cited by 392
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
Gao, M.-Q., Choi, Y.-P., Kang, S., Youn, J. H., & Cho, N.-H. (2010) · Oncogene · doi:10.1038/onc.2010.35 · Cited by 392
Targeting Breast Cancer Stem Cells
Liu, S., & Wicha, M. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5388 · Cited by 356
Combined Targeted Treatment to Eliminate Tumorigenic Cancer Stem Cells in Human Pancreatic Cancer
Mueller, M., Hermann, P. C., Witthauer, J., Rubio–Viqueira, B., Leicht, S. F., Huber, S., Ellwart, J. W., Mustafa, M., Bartenstein, P., D'Haese, J. G., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.053 · Cited by 348
Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells
Viale, A., De Franco, F., Orleth, A., Cambiaghi, V., Giuliani, V., Bossi, D., Ronchini, C., Ronzoni, S., Muradore, I., Monestiroli, S., et al. (2009) · Nature · doi:10.1038/nature07618 · Cited by 305
Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
Rocha, G. Z., Dias, M. M., Ropelle, E. R., Osório-Costa, F., Rossato, F. A., Vercesi, A. E., Saad, M. J. A., & Carvalheira, J. B. C. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2243 · Cited by 305
Metformin: Multi-faceted protection against cancer
Del Barco, S., Vazquez-Martin, A., Cufí, S., Oliveras-Ferraros, C., Bosch-Barrera, J., Joven, J., Martin-Castillo, B., & Menendez, J. A. (2011) · Oncotarget · doi:10.18632/oncotarget.387 · Cited by 302
Li, L., & Bhatia, R. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1499 · Cited by 293
Metformin and cancer: new applications for an old drug
Kourelis, T. V., & Siegel, R. D. (2012) · Medical Oncology · doi:10.1007/s12032-011-9846-7 · Cited by 289
Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
Schatton, T., Schütte, U., Frank, N. Y., Zhan, Q., Hoerning, A., Robles, S. C., Zhou, J., Hodi, F. S., Spagnoli, G. C., Murphy, G. F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1592 · Cited by 287
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
Epelbaum, R., Schaffer, M., Vizel, B., Badmaev, V., & Bar-Sela, G. (2010) · Nutrition and Cancer · doi:10.1080/01635581.2010.513802 · Cited by 282
Moitra, K., Lou, H., & Dean, M. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.14 · Cited by 279
Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics
Calcagno, A. M., Salcido, C. D., Gillet, J.-P., Wu, C.-P., Fostel, J. M., Mumau, M. D., Gottesman, M. M., Varticovski, L., & Ambudkar, S. V. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq361 · Cited by 279
β-Catenin Mediates the Establishment and Drug Resistance of MLL Leukemic Stem Cells
Yeung, J., Esposito, M. T., Gandillet, A., Zeisig, B. B., Griessinger, E., Bonnet, D., & So, C. W. E. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.032 · Cited by 270
On the Stem Cell Origin of Cancer
Sell, S. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091064 · Cited by 257
Funes, J. M., Quintero, M., Henderson, S., Martinez, D., Qureshi, U., Westwood, C., Clements, M. O., Bourboulia, D., Pedley, R. B., Moncada, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700690104 · Cited by 256
Persistent Malignant Stem Cells in del(5q) Myelodysplasia in Remission
Tehranchi, R., Woll, P. S., Anderson, K., Buza-Vidas, N., Mizukami, T., Mead, A. J., Åstrand-Grundström, I., Strömbeck, B., Horvat, A., Ferry, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912228 · Cited by 253
Mathema, V. B., Koh, Y.-S., Thakuri, B. C., & Sillanpää, M. (2012) · Inflammation · doi:10.1007/s10753-011-9346-0 · Cited by 250
Wnt/β-catenin signaling regulates cancer stem cells in lung cancer A549 cells
Teng, Y., Wang, X., Wang, Y., & Ma, D. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.028 · Cited by 250
Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells
Zhou, Y., Zhou, Y., Shingu, T., Feng, L., Chen, Z., Ogasawara, M., Keating, M. J., Kondo, S., & Huang, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.260935 · Cited by 250
Morrison, R., Schleicher, S. M., Sun, Y., Niermann, K. J., Kim, S., Spratt, D. E., Chung, C. H., & Lu, B. (2011) · Journal of Oncology · doi:10.1155/2011/941876 · Cited by 247
Wnt signaling in stem and cancer stem cells
Wend, P., Holland, J. D., Ziebold, U., & Birchmeier, W. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2010.09.004 · Cited by 237
Liu, M., Sakamaki, T., Casimiro, M. C., Willmarth, N. E., Quong, A. A., Ju, X., Ojeifo, J., Jiao, X., Yeow, W.-S., Katiyar, S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0732 · Cited by 227
A clinically relevant population of leukemic CD34+CD38− cells in acute myeloid leukemia
Gerber, J. M., Smith, B. D., Ngwang, B., Zhang, H., Vala, M. S., Morsberger, L., Galkin, S., Collector, M. I., Perkins, B., Levis, M. J., et al. (2012) · Blood · doi:10.1182/blood-2011-06-364182 · Cited by 222
Ionophores: their use as ruminant growth promotants and impact on food safety.
Callaway, T. R., Edrington, T. S., Rychlik, J. L., Genovese, K. J., Poole, T. L., Jung, Y., Bischoff, K. M., Anderson, R. C., & Nisbet, D. J. (2003) · PubMed · Cited by 219
Kallifatidis, G., Labsch, S., Rausch, V., Mattern, J., Gladkich, J., Moldenhauer, G., Büchler, M. W., Salnikov, A. V., & Herr, I. (2011) · Molecular Therapy · doi:10.1038/mt.2010.216 · Cited by 218
Chen, X., Lingala, S., Khoobyari, S., Nolta, J., Zern, M. A., & Wu, J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.043 · Cited by 211
Fuchs, D., Daniel, V., Sadeghi, M., Opelz, G., & Naujokat, C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.138 · Cited by 210
Self-citationRausch, V., Liu, L., Kallifatidis, G., Baumann, B., Mattern, J., Gladkich, J., Wirth, T., Schemmer, P., Büchler, M. W., Zöller, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0066 · Cited by 209
NF-κB pathway inhibitors preferentially inhibit breast cancer stem-like cells
Zhou, J., Zhang, H., Gu, P., Bai, J., Margolick, J. B., & Zhang, Y. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9798-y · Cited by 201
Cancer Stem Cells and Chemosensitivity
Maugeri-Saccà, M., Vigneri, P., & De Maria, R. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2538 · Cited by 201
Comparative Analysis of DNA Repair in Stem and Nonstem Glioma Cell Cultures
Ropolo, M., Daga, A., Griffero, F., Foresta, M., Casartelli, G., Zunino, A., Poggi, A., Cappelli, E., Zona, G., Spaziante, R., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0409 · Cited by 198
CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma
Piao, L. S., Hur, W., Kim, T.-K., Hong, S. W., Kim, S. W., Choi, J. E., Sung, P. S., Song, M. J., Lee, B.-C., Hwang, D., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.10.012 · Cited by 197
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells
Fuchs, D., Heinold, A., Opelz, G., Daniel, V., & Naujokat, C. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.042 · Cited by 196
Self-citationZhang, Y., Zhang, H., Wang, X., Wang, J., Zhang, X., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.072 · Cited by 194
Targeting breast cancer stem cells
McDermott, S. P., & Wicha, M. S. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.06.005 · Cited by 193
Targeting leukemic stem cells by breaking their dormancy
Essers, M. A. G., & Trumpp, A. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.06.001 · Cited by 188
Cancer stem cells in solid tumors
Hermann, P. C., Bhaskar, S., Cioffi, M., & Heeschen, C. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.03.004 · Cited by 180
Vazquez-Martin, A., Oliveras-Ferraros, C., Barco, S. D., Martin-Castillo, B., & Menendez, J. A. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0924-x · Cited by 179
Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds
Li, Y., Wicha, M. S., Schwartz, S. J., & Sun, D. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.11.001 · Cited by 179
Cancer Stem Cell–Directed Therapies: Recent Data From the Laboratory and Clinic
Park, C. Y., Tseng, D., & Weissman, I. L. (2009) · Molecular Therapy · doi:10.1038/mt.2008.254 · Cited by 178
The Role of Breast Cancer Stem Cells in Metastasis and Therapeutic Implications
Velasco-Velázquez, M. A., Popov, V. M., Lisanti, M. P., & Pestell, R. G. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.03.005 · Cited by 178
Kim, K.-Y., Yu, S.-N., Lee, S.-Y., Chun, S.-S., Choi, Y.-L., Park, Y.-M., Song, C. S., Chatterjee, B., & Ahn, S.-C. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.054 · Cited by 176
Clinical Experience With Hedgehog Pathway Inhibitors
Low, J. A., & de Sauvage, F. J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.27.9943 · Cited by 175
Chen, M. S., Woodward, W. A., Behbod, F., Peddibhotla, S., Alfaro, M. P., Buchholz, T. A., & Rosen, J. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.03348 · Cited by 170
Lagadec, C., Vlashi, E., Della Donna, L., Meng, Y., Dekmezian, C., Kim, K., & Pajonk, F. (2010) · Breast Cancer Research · doi:10.1186/bcr2479 · Cited by 167
Models of carcinogenesis: an overview
Vineis, P., Schatzkin, A., & Potter, J. D. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq087 · Cited by 165
Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells
Majeti, R. (2010) · Oncogene · doi:10.1038/onc.2010.511 · Cited by 164
Cancer Stem Cells: At the Headwaters of Tumor Development
Ward, R. J., & Dirks, P. B. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.091847 · Cited by 164
Awad, O., Yustein, J. T., Shah, P., Gul, N., Katuri, V., O'Neill, A., Kong, Y., Brown, M. L., Toretsky, J. A., & Loeb, D. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013943 · Cited by 163
ABCG2: the key to chemoresistance in cancer stem cells?
An, Y., & Ongkeko, W. M. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903228834 · Cited by 162
Antibodies targeting cancer stem cells: A new paradigm in immunotherapy?
Deonarain, M. P., Kousparou, C. A., & Epenetos, A. A. (2009) · mAbs · doi:10.4161/mabs.1.1.7347 · Cited by 159
Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress
Ketola, K., Hilvo, M., Hyötyläinen, T., Vuoristo, A., Ruskeepää, A.-L., Orešič, M., Kallioniemi, O., & Iljin, K. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.530 · Cited by 159
Salinomycin inhibits osteosarcoma by targeting its tumor stem cells
Tang, Q.-L., Zhao, Z.-Q., Li, J.-C., Liang, Y., Yin, J.-Q., Zou, C.-Y., Xie, X.-B., Zeng, Y.-X., Shen, J.-N., Kang, T., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.016 · Cited by 159
Cancer Stem Cells and Novel Targets for Antitumor Strategies
Prud’homme, G. J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800626120 · Cited by 150
Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells
Nautiyal, J., Kanwar, S. S., Yu, Y., & Majumdar, A. P. N. (2011) · Journal of Molecular Signaling · doi:10.1186/1750-2187-6-7 · Cited by 150
The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor
Riccioni, R., Dupuis, M. L., Bernabei, M., Petrucci, E., Pasquini, L., Mariani, G., Cianfriglia, M., & Testa, U. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.03.008 · Cited by 149
PTEN, Stem Cells, and Cancer Stem Cells
Hill, R., & Wu, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800071200 · Cited by 145
Cufí, S., Corominas-Faja, B., Vázquez‐Martín, A., Oliveras‐Ferraros, C., Dorca, J., Bosch‐Barrera, J., Martín-Castillo, B., & Menéndez, J. A. (2012) · Oncotarget · doi:10.18632/oncotarget.488 · Cited by 144
Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist
Prud’homme, G. J., Glinka, Y., Toulina, A., Ace, O., Subramaniam, V., & Jothy, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013831 · Cited by 143
Breast cancer stem cells: treatment resistance and therapeutic opportunities
Al‐Ejeh, F., Smart, C. E., Morrison, B. J., Chenevix‐Trench, G., López, J. A., Lakhani, S. R., Brown, M. P., & Khanna, K. K. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr028 · Cited by 134
Kim, J.-H., Chae, M.-J., Kim, W. K., Kim, Y., Kang, H. S., Kim, H. S., & Yoon, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01089.x · Cited by 133
Targeting Cancer Stem Cells with Phytochemicals
Kawasaki, B. T., Hurt, E., Mistree, T., & Farrar, W. L. (2008) · Molecular Interventions · doi:10.1124/mi.8.4.9 · Cited by 130
Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells
Zhang, G.-N., Liang, Y., Zhou, L.-J., Chen, S.-P., Chen, G., Zhang, T., Kang, T., & Zhao, Y.-P. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.05.030 · Cited by 130
Reim, F., Dombrowski, Y., Ritter, C., Buttmann, M., Häusler, S. F., Ossadnik, M., Krockenberger, M., Beier, D., Beier, C. P., Dietl, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0834 · Cited by 129
Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells
Kobune, M., Takimoto, R., Murase, K., Iyama, S., Sato, T., Kikuchi, S., Kawano, Y., Miyanishi, K., Sato, Y., Niitsu, Y., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01111.x · Cited by 126
Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
Rattan, R., Fehmi, R.-A., & Munkarah, A. R. (2012) · Journal of Oncology · doi:10.1155/2012/928127 · Cited by 126
Dong, T., Zhou, H., Wang, L., Feng, B., Lv, B., & Zheng, M.-H. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1561-2 · Cited by 124
Crucial Role of Interleukin-4 in the Survival of Colon Cancer Stem Cells
Francipane, M. G., Alea, M. P., Lombardo, Y., Todaro, M., Medema, J. P., & Stassi, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6874 · Cited by 120
Bardsley, M., Horvath, V., Asuzu, D. T., Lorincz, A., Redelman, D., Hayashi, Y., Popko, L., Young, D., Lomberk, G., Urrutia, R., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.083 · Cited by 119
Identification of CD133-Positive Radioresistant Cells in Atypical Teratoid/ Rhabdoid Tumor
Chiou, S., Kao, C.-L., Chen, Y., Chien, C., Hung, S., Lo, J., Chen, Y.-J., Ku, H., Hsu, M., & Wong, T. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002090 · Cited by 118
Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance
Chiu, P., Jiang, H., & Dick, J. E. (2010) · Blood · doi:10.1182/blood-2010-06-292300 · Cited by 117
Martelli, A. M., Evangelisti, C., Follo, M., Ramazzotti, G., Fini, M., Giardino, R., Manzoli, L., McCubrey, J. A., & Cocco, L. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796011201 · Cited by 116
Gallmeier, E., Hermann, P. C., Mueller, M.-T., Machado, J. G., Ziesch, A., Toni, E. N. D., Palagyi, A., Eisen, C., Ellwart, J. W., Rivera, J., et al. (2011) · Stem Cells · doi:10.1002/stem.595 · Cited by 106
Kim, M. R., Choi, H., Cho, K. B., Kim, H. S., & Kang, K. W. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01260.x · Cited by 101
Salinomycin in cancer: A new mission for an old agent
Naujokat (2010) · Molecular Medicine Reports · doi:10.3892/mmr_00000296 · Cited by 97
Parmar, A., Marz, S., Rushton, S. N., Holzwarth, C., Lind, K., Käyser, S., Döhner, K., Peschel, C., Oostendorp, R. A. J., & Götze, K. S. S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4136 · Cited by 96
Apoptosis and cancer stem cells: Implications for apoptosis targeted therapy
Kruyt, F. A. E., & Schuringa, J. J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.010 · Cited by 88
Concise Review: Cancer Stem Cells and Minimal Residual Disease
Ghiaur, G., Gerber, J. M., & Jones, R. J. (2011) · Stem Cells · doi:10.1002/stem.769 · Cited by 84
Markers of Tumor-Initiating Cells Predict Chemoresistance in Breast Cancer
Gong, C., Yao, H., Liu, Q., Chen, J., Shi, J., Su, F., & Song, E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015630 · Cited by 80
Phenotypic Heterogeneity of Breast Cancer Stem Cells
Lorico, A., & Rappa, G. (2011) · Journal of Oncology · doi:10.1155/2011/135039 · Cited by 79
Molecular biology of breast cancer stem cells: Potential clinical applications
Nguyen, N. P., Almeida, F. S., Chi, A., Nguyen, L. M., Cohen, D. J., Karlsson, U. L., & Vinh‐Hung, V. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.02.016 · Cited by 79
Oak, P., Kopp, F. B., Thakur, C., Ellwart, J. W., Rapp, U. R., Ullrich, A., Wagner, E., Knyazev, P. G., & Roidl, A. (2012) · International Journal of Cancer · doi:10.1002/ijc.27595 · Cited by 75
Stemming Resistance to HER-2 Targeted Therapy
Bedard, P. L., Cardoso, F., & Piccart, M. J. (2009) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-009-9116-x · Cited by 71
Martı́n-Castillo, B., Dorca, J., Vázquez‐Martín, A., Oliveras‐Ferraros, C., López‐Bonet, E., García, M., del Barco, S., & Menéndez, J. A. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp494 · Cited by 64
On the epigenetic origin of cancer stem cells
Vincent, A., & SEUNINGEN, I. V. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.03.009 · Cited by 55
Gould, A., & Missailidis, S. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711795049871 · Cited by 53
A phase I study of temsirolimus and metformin in advanced solid tumours
MacKenzie, M. J., Ernst, S., Johnson, C., & Winquist, E. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9570-8 · Cited by 52
Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine
Winquist, R. J., Boucher, D. M., Wood, M. L., & Furey, B. F. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.020 · Cited by 45
Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas
Basu, D., Montone, K. T., Wang, L., Gimotty, P. A., Hammond, R., Diehl, J. A., Rustgi, A. K., Lee, J. T., Räsänen, K., Weinstein, G. S., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.12.15883 · Cited by 44
Park, J. H., Park, S. J., Chung, M. K., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.142 · Cited by 37
Dormancy in the stem cell niche
Sottocornola, R., & Celso, C. L. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt101 · Cited by 36
Targeting Cancer Stem Cells with Natural Products
Burnett, J., Newman, B. W., & Sun, D. (2012) · Current Drug Targets · doi:10.2174/138945012802009062 · Cited by 33
The ABCs of cancer stem cell drug resistance.
Elliott, A., Elliot, A., Adams, J. M., & Al‐Hajj, M. (2010) · PubMed · Cited by 32
Differentiation pathways in carcinogenesis and in chemo- and radioresistance
Janíková, M., & Škarda, J. (2011) · Neoplasma · doi:10.4149/neo_2012_002 · Cited by 29
Cited by
Salinomycin kills cancer stem cells by sequestering iron in lysosomes
Mai, T. T., Hamaï, A., Hienzsch, A., Cañeque, T., Müller, S., Wicinski, J., Cabaud, O., Leroy, C., David, A., Acevedo, V., et al. (2017) · Nature Chemistry · doi:10.1038/nchem.2778 · Cited by 612
Jung, Y.-S., & Park, J.-I. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0380-6 · Cited by 419
Poloxamer Hydrogels for Biomedical Applications
Russo, E., & Villa, C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11120671 · Cited by 408
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
Li, Y., Li, P.-K., Roberts, M. J., Arend, R. C., Samant, R. S., & Buchsbaum, D. J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.04.003 · Cited by 364
The role of microRNAs in the regulation of cancer stem cells
Takahashi, R.-U., Miyazaki, H., & Ochiya, T. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2013.00295 · Cited by 118
Metadata
- Authors
- Naujokat, C., & Steinhart, R.
- Venue
- Journal of Biomedicine and Biotechnology
- Publisher
- Hindawi Limited
- Published
- 2012
- Volume
- 2012
- Pages
- 1-17
- ISSN
- 1110-7243 (ISSN-L)
- 1110-7251
- OpenAlex
- W2006307101
- Cited by
- 351
- References
- 155
- FWCI
- 10.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.